Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs

• Published in: World journal of surgical oncology 2024-04, Vol.22 (1), p.98-98, Article 98
• Main Authors: Watanabe, Akie, Rai, Sabrina, Yip, Lily, Brown, Carl J, Loree, Jonathan M, Stuart, Heather C
• Format: Article
• Language: English
• Subjects: Female; Humans; Kaplan-Meier Estimate; Male; Neoplasm Staging; Neuroendocrine Tumors - pathology; Rectal Neoplasms - pathology; Retrospective Studies
• ISSN: 1477-7819; 1477-7819
• DOI: 10.1186/s12957-024-03379-5

Rectal neuroendocrine tumors (RNETs) are often discovered on screening colonoscopy. Indications for staging and definitive resection are inconsistent in current guidelines. We evaluated the role of grade in guiding staging and procedural decision-making. Patients with biopsy confirmed RNETs between 2004 and 2015 were reviewed. Baseline characteristics, staging investigations (biochemical and imaging), and endoscopic/surgical treatment were recorded. Associations between grade, preoperative staging, interventions, and survival were determined using Fisher-Freeman-Halton Exact, log-rank, and Kaplan-Meier analysis. Amongst 139 patients with RNETs, 9% were aged ≥ 75 years and 44% female. Tumor grade was: 73% grade 1 (G1), 18%, grade 2 (G2) and 9% grade 3 (G3). Staging investigations were performed in 52% of patients. All serum chromogranin A and 97% of 24-hour urine 5-hydroxyindoleacetic acid tests were normal. The large majority of staging computed tomography (CT) scans were negative (76%) with subgroup analysis showing no G1 patients with CT identified distant disease compared with 38% of G2 and 50% of G3 patients (p